A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375
Clinical trial NCT05026008 · COMPLETED
Trial details
- NCT number
- NCT05026008
- Sponsor
- Shanghai SIMR Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-11-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.